Addex Therapeutics Ltd Share Price
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
16:31:43 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0222 CHF | +4.72% |
|
-2.63% | -59.93% |
| 10-08 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 10-08 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
| Market Cap | 2.83M 3.42M 3.05M 2.58M 4.85M 325M 4.94M 34.04M 13.31M 169M 12.84M 12.57M 540M | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 1.22M 1.48M 1.32M 1.12M 2.1M 141M 2.14M 14.74M 5.76M 73.28M 5.56M 5.44M 234M | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
43.94% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| ADXN | Delayed | |
CBOE
| 0QNV | Real-time | |
|
Deutsche Boerse AG
| APE | Delayed | |
|
Börse Stuttgart
| APE | Delayed | |
|
Boerse Muenchen
| APE | Real-time |
Last Transcript: Addex Therapeutics Ltd
| 1 day | +4.72% | ||
| 1 week | -2.63% | ||
| Current month | +7.77% | ||
| 1 month | -9.02% | ||
| 3 months | -43.65% | ||
| 6 months | -52.77% | ||
| Current year | -59.93% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.03 |
| Current year | 0.02 | | 0.07 |
| 1 year | 0.02 | | 0.07 |
| 3 years | 0.02 | | 0.26 |
| 5 years | 0.02 | | 1.38 |
| 10 years | 0.02 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 31/05/2013 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 31/05/2017 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 27/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 31/12/2014 |
Ray Hill
BRD | Director/Board Member | 81 | 11/05/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Issuer sale | Chief Technology Officer | -885,674 | 0.4051% | ||
| 02/09/26 | Issuer sale | Director | -539,122 | 0.2466% | ||
| 02/09/26 | Issuer sale | Chief Financial Officer | -1,205,816 | 0.5515% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.72% | -2.63% | -62.37% | -66.77% | 3.22M | |
| +0.21% | -7.67% | +61.07% | +71.32% | 68.92B | |
| +1.66% | -9.54% | +10.39% | +60.04% | 51.9B | |
| +3.14% | +4.61% | +15.36% | +44.42% | 48.73B | |
| +3.45% | +5.01% | +32.37% | +35.96% | 43.13B | |
| -2.20% | -5.78% | +298.44% | +532.76% | 41.48B | |
| +6.43% | +2.76% | +16.56% | +109.23% | 39.96B | |
| +1.28% | -0.76% | +12.67% | +45.10% | 30.6B | |
| -2.21% | -14.22% | +40.33% | -0.94% | 26.01B | |
| +1.74% | -5.30% | -12.09% | -12.92% | 22.27B | |
| Average | +1.82% | -4.21% | +41.27% | +81.82% | 37.3B | |
| Weighted average by Cap. | +1.58% | -3.49% | +56.57% | +105.30% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 496K 442K 373K 703K 47.16M 716K 4.93M 1.93M 24.54M 1.86M 1.82M 78.3M | 173K 209K 186K 157K 296K 19.88M 302K 2.08M 813K 10.34M 785K 768K 33.01M |
| Net income | 7.06M 8.53M 7.6M 6.42M 12.1M 811M 12.32M 84.92M 33.2M 422M 32.03M 31.37M 1.35B | -6.73M -8.13M -7.25M -6.13M -11.54M -774M -11.75M -80.97M -31.66M -403M -30.54M -29.91M -1.28B |
| Net Debt | -3.3M -3.99M -3.56M -3M -5.66M -379M -5.76M -39.71M -15.53M -197M -14.98M -14.67M -630M | -1.6M -1.94M -1.73M -1.46M -2.75M -184M -2.8M -19.3M -7.55M -95.97M -7.28M -7.13M -306M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | CHF 0.0222 | +4.72% | 1,062,587 |
| 14/10/26 | CHF 0.0212 | -9.40% | 173,670 |
| 13/10/26 | CHF 0.0234 | 0.00% | 378,303 |
| 12/10/26 | CHF 0.0234 | +0.86% | 203,713 |
| 09/10/26 | CHF 0.0232 | -2.52% | 336,028 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
